Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

Background/Purpose: For extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae infections, carbapenems are recommended as first line therapy, and clinical data on the therapeutic efficacy of fluoroquinolones (FQs) is limited. This study compares the efficacy of FQs and carbapenems for...

Full description

Bibliographic Details
Main Authors: Ching-Lung Lo, Ching-Chi Lee, Chia-Wen Li, Ming-Chi Li, Po-Ren Hsueh, Nan-Yao Lee, Wen-Chien Ko
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
bloodstream infections
carbapenem
Enterobacteriaceae
ESBL
fluoroquinolone
Online Access:http://www.sciencedirect.com/science/article/pii/S168411821500835X

Internet

http://www.sciencedirect.com/science/article/pii/S168411821500835X

Similar Items